Bellaire Clinical Research, LLC

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)2 trials
• Obesity1 trial
• Type 2 diabetes1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Recruiting3 trials

Lead sponsor

• Boehringer Ingelheim1 trial
• Hoffmann-La Roche1 trial
• Rivus Pharmaceuticals, Inc.1 trial

Running trials

• Recruiting

  A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  NCT07351045· Phase 3· Hoffmann-La Roche· Source

• Recruiting

  A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)

  NCT07491458· Phase 2· Rivus Pharmaceuticals, Inc.· Source

  Contact: Layla Haider

• Recruiting

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  NCT06632444· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)2 recruiting
• Obesity1 recruiting
• Type 2 diabetes1 recruiting